Section: 
School of pharmacotherapy
School of pharmacotherapyThe place of the immunomodulator Galavit in the complex treatment of chronic inflammatory pathology of ENT organs
N. E. Paiganova (1), V. M. Zaitsev (2)
(1) Pirogov Russian National Research Medical University, Moscow, 117997, Russia, (2) ENT Сlinic of Dr. Zaitsev, Moscow, 115054, Russia
UDK: УДК 616.921.5-022.6-08-039.7
DOI: https://doi.org/10.18692/1810-4800-2023-5-111-118
ABSTRACT
Chronic inflammatory pathology of ENT organs is a group of diseases that an otorhinolaryngologist faces daily at an outpatient department. According to modern data, secondary immunodeficiency plays the main role in the chronization of inflammatory processes in ENT organs. For the purpose of correction, it is rational to add immunomodulators to standard therapy. An observational study was conducted on the comparative effectiveness of complex outpatient treatment of chronic tonsillitis and chronic rhinosinusitis using the immunomodulatory drug Galavit in clinical practice. Reliable data were obtained on the effect of the immunomodulator Galavit to increase in the duration of remission in chronic tonsillitis – up to 8 months on average, in chronic catarrhal rhinosinusitis – up to 8.5 months on average, a decrease in the frequency, duration and severity of the course of flu in chronic inflammatory pathology of ENT organs.
Publication date:
25.10.2023
Keywords:
chronic tonsillopharyngitis, chronic catarrhal rhinosinusitis, complex treatment, immunomo-dulators, Galavit, aminodihydrophthalazinedione sodium, secondary immune deficiencies. For citation:
Paiganova N. E., Zaitsev V. M. The place of the immunomodulator Galavit in the complex treatment of chronic inflammatory pathology of ENT organs. Russian Otorhinolaryngology. 2023;22(5):111-118. https://doi.org/10.18692/1810-4800-2023-5-111-118